Sunday, September 7, 2025

Common allergy spray slashes COVID-19 risk in surprising trial

A common hay fever nasal spray was found to cut COVID-19 infections by two-thirds in a clinical trial, while also reducing rhinovirus cases. Researchers believe it could serve as an easy, low-cost preventive measure, pending further studies.

from Top Health News -- ScienceDaily https://ift.tt/fDmxMdH

No comments:

Post a Comment

He survived 48 hours without lungs and lived

A critically ill 33-year-old man survived an almost unimaginable scenario—living for 48 hours without lungs—thanks to a groundbreaking surgi...